Showing results (951-960 of 5,585) with videos related to
Sort By:
Pageof 559
Nuclear Medicine Communications|August 31, 2011
Comparing two TAG-72 binding peptides previously identified by phage display as potential imaging agentsLing Chen, Yi Wang, Dengfeng Cheng, et al.Nuclear Medicine Communications|August 31, 2011
Low-dose (123)I-metaiodobenzylguanidine diagnostic scan is inferior to (131)I-metaiodobenzylguanidine posttreatment scan in detection of malignant pheochromocytoma and paragangliomaDaiki Kayano, Junichi Taki, Makoto Fukuoka, et al.Nuclear Medicine Communications|October 6, 2011
Diffuse increased splenic F-18 fluorodeoxyglucose uptake may be an indirect sign of acute pyogenic cause rather than tuberculous in patients with infectious spondylitisKeunyoung Kim, Seong-Jang Kim, In Joo Kim, et al.Nuclear Medicine Communications|October 6, 2011
Specificity and sensitivity of ⁹⁹mTc-EDDA/HYNIC-Tyr³-octreotide (⁹⁹mTc-TOC) for imaging neuroendocrine tumorsJesús Sepúlveda-Méndez, Consuelo Arteaga de Murphy, Martha Pedraza-López, et al.Nuclear Medicine Communications|October 18, 2011
Results from an Australian and New Zealand audit of left ventricular ejection fraction from gated heart pool scan analysisElizabeth A Bailey, Dale L BaileyNuclear Medicine Communications|March 17, 2012
Nuclear medicine imaging in tuberculosis using commercially available radiopharmaceuticalsMike Sathekge, Alex Maes, Yves D'Asseler, et al.Nuclear Medicine Communications|March 8, 2012
Risk factors for extensive skeletal muscle uptake in oncologic FDG-PET/CT for patients undergoing a 4-h fastKoya Nakatani, Yuji Nakamoto, Kaori TogashiNuclear Medicine Communications|February 24, 2012
Diagnostic value of PET/CT is similar to that of conventional MRI and even better for detecting small peritoneal implants in patients with recurrent ovarian cancerYasemin Sanli, Cuneyt Turkmen, Baris Bakir, et al.Nuclear Medicine Communications|April 13, 2012
Brain perfusion SPECT imaging and acetazolamide challenge in vascular cognitive impairmentKarim Farid, Slavomir Petras, Valérie Ducasse, et al.Nuclear Medicine Communications|November 19, 2010
Evaluation of [18F]-tetrafluoroborate as a potential PET imaging agent for the human sodium/iodide symporter in a new colon carcinoma cell line, HCT116, expressing hNISAmanda J Weeks, Maite Jauregui-Osoro, Marcel Cleij, et al.Pageof 559